CPT 82043: Urine Albumin Quantitative Assay
Commercial payers pay $18 on average nationally for this procedure.
CPT code 82043 describes a laboratory test in which a lab analyst quantitates albumin in a timed or random urine specimen to assess urinary albumin excretion, a diagnostic and monitoring assay for kidney disease; service type: clinical laboratory quantitative assay; typical site of service: hospital or independent clinical laboratory where urine specimens are collected and analyzed.
Customize your policy alerts
Sign up for cpt 82043 policy alerts
Get alerted when payer policies referencing 82043 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for CPT 82043 centers around an average commercial benchmark represented by BUCA at $18.50. Blue Cross Blue Shield shows the highest central tendency with a median of $25.10 and a mean of $27.40, while Aetna, Cigna, and UnitedHealth Group cluster lower with means of $7.80, $6.60, and $5.10 respectively. BUCA’s average sits between those clusters and helps frame the market midpoint for commercial contracts at $18.50.
Dispersion varies notably: Blue Cross Blue Shield has the widest interquartile spread (P75–P25 = $9.80), indicating greater variability across its contracted rates, while UnitedHealth Group is the tightest with a spread of $3.40. Aetna and Cigna show moderate spreads of $4.90 and $4.50 respectively, suggesting more consistent pricing than Blue Cross Blue Shield but less consistency than UnitedHealth Group. BUCA provides a single average benchmark without quartile extremes.